# An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)

> **NCT00530361** · PHASE3 · WITHDRAWN · sponsor: **Scios, Inc.**

## Conditions studied

- Coronary Artery Bypass Surgery
- Coronary Heart Disease
- Coronary Artery Bypass Grafting
- Cardiopulmonary Bypass
- Ischemic Heart Disease
- Heart Failure, Congestive

## Interventions

- **DRUG:** Nesiritide

## Key facts

- **NCT ID:** NCT00530361
- **Lead sponsor:** Scios, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2009-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was withdrawn prior to patient dosing based on a business decision.
- **Last updated:** 2016-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530361, "An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00530361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*